About Joseph Papa
Joseph Papa is a director at Candel Therapeutics.
Form D filings name Joseph Papa as a director at Mirador Therapeutics.
Joseph Papa reports to the SEC as a director or officer of 8 public companies, including Milestone Pharmaceuticals (MIST), Emergent BioSolutions (EBS) and Prometheus Biosciences (RXDX).
Joseph Papa first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Joseph Papa in the role, so the role may have started earlier or lasted longer.
CI
Candel Therapeutics, Inc.
Director
2022 – 2026 · Public company (CADL)
MI
Milestone Pharmaceuticals Inc.
Director
2024 – 2026 · Public company (MIST)
EI
Emergent BioSolutions Inc.
President and CEO, director
2024 – 2026 · Public company (EBS)
PI
Prometheus Biosciences, Inc.
Director
2021 – 2023 · Public company (RXDX)
BI
Bausch Health Companies Inc.
Chairman & CEO
2016 – 2022 · Public company (BHC)
BC
Bausch & Lomb Corp
CEO & Chairman
2022 · Public company (BLCO)
PP
Perrigo Co. PLC
Director
2013 – 2016 · Public company (PRGO)
PC
Perrigo Co.
President and CEO, director
2006 – 2013 · Public company (PRGO)
Key Colleagues at Startups
The people Joseph Papa works with at each company, as listed on that company's latest Form D.
Mirador Therapeutics, Inc. · Form D, Apr 3, 2024
PB
Paul Berns
Director
MM
Mark McKenna
Executive officer and director
SG
Scott Glenn
Director
KB
Kristina Burow
Director
VB
Vika Brough
Executive officer
DD
David Bonita, M.D.
Director
TA
Timothy Andrews
Secretary